NPPA and myeloid sarcoma: Contrary to a contributing role in acute pathogenesis, mounting evidence from numerous EAE studies implicates IDO and specific KP metabolites in limiting autoimmunity and promoting immune tolerance, which might, in part, account for the periodic remissions observed in MS and EAE.